Literature DB >> 8417050

Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope.

H R Middlekauff1, W G Stevenson, L W Stevenson, L A Saxon.   

Abstract

OBJECTIVES: The purpose of this study was to assess the importance of syncope as a warning sign for sudden death in advanced heart failure and to determine the relative importance of cardiac syncope and syncope from other causes.
BACKGROUND: Despite remarkable advances in the pharmacologic approach to advanced heart failure, 20% to 40% of patients with advanced heart failure will die each year. In such patients, the relation between sudden death and the etiology of syncope has not been evaluated.
METHODS: The relation of syncope to sudden death was evaluated in 491 consecutive patients with advanced heart failure (New York Heart Association functional class III or IV), no history of cardiac arrest and a mean left ventricular ejection fraction of 0.20 +/- 0.07. Patients were evaluated for the presence and origin of syncope. The severity of heart failure was assessed from serum sodium levels, ejection fraction, functional class and echocardiographic and hemodynamic variables.
RESULTS: Sixty patients (12%) had a history of syncope; the condition had a cardiac origin in 29 (48%) and was due to other causes in 31 (52%). The origin of heart failure was coronary artery disease in 234 patients (48%) and dilated cardiomyopathy in 253 (51%) and its severity was similar in patients with and without syncope. During a mean follow-up interval of 365 +/- 419 days, 69 patients (14%) died suddenly and 66 patients (13%) died of progressive heart failure. The actuarial incidence of sudden death by 1 year was significantly greater in patients with (45%) than in those without (12%, p < 0.00001) syncope. In the Cox proportional hazards model, syncope predicted sudden death independent of atrial fibrillation, serum sodium, cardiac index, angiotensin-converting enzyme inhibition and patient age. The actuarial risk of sudden death by 1 year was similarly high in patients with either cardiac syncope or syncope from other causes (49% vs. 39%, p = NS).
CONCLUSIONS: Patients with advanced heart failure are at especially high risk for sudden death regardless of the etiology of syncope.

Entities:  

Mesh:

Year:  1993        PMID: 8417050     DOI: 10.1016/0735-1097(93)90724-f

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  40 in total

1.  Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function.

Authors:  P F Bakker; H W Meijburg; J W de Vries; M M Mower; A C Thomas; M L Hull; E O Robles De Medina; J J Bredée
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

2.  The role of echocardiography in diagnostic evaluation of patients with syncope-a retrospective analysis.

Authors:  Ali Raza Ghani; Waqas Ullah; Hafez Mohammad Ammar Abdullah; Yasar Sattar; Usman Sarwar; Irfan Ahsan; Wajahat Humayun
Journal:  Am J Cardiovasc Dis       Date:  2019-10-15

3.  Patterns and preexisting risk factors of 30-day mortality after a primary discharge diagnosis of syncope or near syncope.

Authors:  Stephen F Derose; Gelareh Z Gabayan; Vicki Y Chiu; Benjamin C Sun
Journal:  Acad Emerg Med       Date:  2012-05       Impact factor: 3.451

Review 4.  Relationship of the implantable cardioverter defibrillator and chronic resynchronization therapy: the perfect marriage?

Authors:  David S Cannom; Morton Mower
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-10       Impact factor: 1.468

5.  [Commentary on the guidelines the diagnosis and the therapy of syncope--the European Society of Cardiology 2001 and the update 2004].

Authors:  K Seidl; A Schuchert; J Tebbenjohanns; W Hartung
Journal:  Z Kardiol       Date:  2005-09

Review 6.  How to avoid a misdiagnosis in patients presenting with transient loss of consciousness.

Authors:  Sanjiv Petkar; Paul Cooper; Adam P Fitzpatrick
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

7.  [Reflex syncope : diagnosis and therapy].

Authors:  K Seidl; W von Scheidt; C Pfafferott
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-04-15

8.  Role of echocardiography in the evaluation of syncope: a prospective study.

Authors:  F P Sarasin; A-F Junod; D Carballo; S Slama; P-F Unger; M Louis-Simonet
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 9.  Syncope: investigation and treatment.

Authors:  Satish R Raj; Robert S Sheldon
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

10.  Current Management of Syncope: Treatment Alternatives.

Authors:  Carlos A. Morillo; Adrián Baranchuk
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.